Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2346.25 and 2465.85
| Intraday Target 1 | 2324.43 |
| Intraday Target 2 | 2368.07 |
| Intraday Target 3 | 2444.0333333333 |
| Intraday Target 4 | 2487.67 |
| Intraday Target 5 | 2563.63 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 13 May 2026 | 2411.70 (-1.52%) | 2449.90 | 2400.40 - 2520.00 | 1.3592 times | Tue 12 May 2026 | 2448.80 (0.52%) | 2436.20 | 2407.40 - 2493.70 | 0.8291 times | Mon 11 May 2026 | 2436.20 (-1.64%) | 2476.90 | 2430.50 - 2476.90 | 0.3142 times | Fri 08 May 2026 | 2476.90 (-0.18%) | 2481.30 | 2441.00 - 2504.90 | 0.6704 times | Thu 07 May 2026 | 2481.30 (2.39%) | 2423.50 | 2423.50 - 2490.00 | 1.279 times | Wed 06 May 2026 | 2423.30 (2.52%) | 2380.00 | 2365.00 - 2450.00 | 0.6907 times | Tue 05 May 2026 | 2363.70 (0.59%) | 2335.00 | 2335.00 - 2399.00 | 1.0219 times | Mon 04 May 2026 | 2349.90 (0.58%) | 2342.00 | 2322.50 - 2387.40 | 1.1248 times | Thu 30 April 2026 | 2336.40 (-1.28%) | 2367.20 | 2319.40 - 2370.80 | 1.1207 times | Wed 29 April 2026 | 2366.60 (-1.81%) | 2415.00 | 2359.50 - 2428.50 | 1.59 times | Tue 28 April 2026 | 2410.20 (-1.19%) | 2450.00 | 2404.20 - 2466.30 | 0.5234 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2346.25 and 2465.85
| Weekly Target 1 | 2324.43 |
| Weekly Target 2 | 2368.07 |
| Weekly Target 3 | 2444.0333333333 |
| Weekly Target 4 | 2487.67 |
| Weekly Target 5 | 2563.63 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 13 May 2026 | 2411.70 (-2.63%) | 2476.90 | 2400.40 - 2520.00 | 0.8907 times | Fri 08 May 2026 | 2476.90 (6.01%) | 2342.00 | 2322.50 - 2504.90 | 1.7038 times | Thu 30 April 2026 | 2336.40 (-5.49%) | 2472.00 | 2319.40 - 2495.00 | 1.5786 times | Fri 24 April 2026 | 2472.00 (0.74%) | 2465.00 | 2397.10 - 2529.90 | 0.8435 times | Fri 17 April 2026 | 2453.90 (2.5%) | 2370.10 | 2341.20 - 2468.80 | 0.7081 times | Fri 10 April 2026 | 2394.00 (3.57%) | 2307.00 | 2267.80 - 2431.80 | 0.8034 times | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 1.0843 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 0.882 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.6428 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.8629 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.8343 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2367.1 and 2564.6
| Monthly Target 1 | 2220.57 |
| Monthly Target 2 | 2316.13 |
| Monthly Target 3 | 2418.0666666667 |
| Monthly Target 4 | 2513.63 |
| Monthly Target 5 | 2615.57 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 13 May 2026 | 2411.70 (3.22%) | 2342.00 | 2322.50 - 2520.00 | 0.4657 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.8191 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.66 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9631 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8603 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.406 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1727 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7615 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.213 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.6787 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 1.0249 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2063.55 and 2565.75
| Yearly Target 1 | 1947.5 |
| Yearly Target 2 | 2179.6 |
| Yearly Target 3 | 2449.7 |
| Yearly Target 4 | 2681.8 |
| Yearly Target 5 | 2951.9 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 13 May 2026 | 2411.70 (-2.5%) | 2476.00 | 2217.60 - 2719.80 | 0.3325 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6231 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2301 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2397 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7201 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9605 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0719 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4585 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2332 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1304 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1307 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. But this trend seems to be weakening.
Price is below an important level of 2424.57 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 50 as on Wed 13 May 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2426 and price is deviating by 44 points
Upper Bollinger band is at 2513 and lower is at 2339, while middle bands are at 2383 and 2470
Price is coming down
Price is below 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2402.15 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2450.98 |
| 12 day DMA | 2412.02 |
| 20 day DMA | 2425.63 |
| 35 day DMA | 2387.7 |
| 50 day DMA | 2422.51 |
| 100 day DMA | 2449.03 |
| 150 day DMA | 2504.23 |
| 200 day DMA | 2586.48 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2431.6 | 2441.55 | 2437.93 |
| 12 day EMA | 2424.59 | 2426.93 | 2422.95 |
| 20 day EMA | 2420.24 | 2421.14 | 2418.23 |
| 35 day EMA | 2431.93 | 2433.12 | 2432.2 |
| 50 day EMA | 2439.89 | 2441.04 | 2440.72 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2450.98 | 2453.3 | 2436.28 |
| 12 day SMA | 2412.02 | 2417.04 | 2420.86 |
| 20 day SMA | 2425.63 | 2425.76 | 2423.02 |
| 35 day SMA | 2387.7 | 2388.44 | 2387.89 |
| 50 day SMA | 2422.51 | 2426.64 | 2430.44 |
| 100 day SMA | 2449.03 | 2450.92 | 2452.65 |
| 150 day SMA | 2504.23 | 2505.88 | 2507.31 |
| 200 day SMA | 2586.48 | 2590.12 | 2593.74 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 40.01
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 42.77
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
